HOME >> BIOLOGY >> NEWS
Clinical judgement still counts strongly alongside genetic testing

The study found that locally, nationally and internationally specialists in dysmorphology are recognised by their professional peers as having knowledge and authority in the field.

The field of dysmorphology embraces on the one hand the new medical technologies being employed and interpreted, and on the other the long-standing features of clinical medicine. Interviews with families of dysmorphic children revealed that, for some, identifiying a genetic reason for various problems and delay in development can provide a source of satisfaction. It can remove doubt and uncertainty as to the condition itself.

Some parents have real concerns over the possibility that they are in some way responsible for their children's problems. In particular they worry whether their lifestyle choices, such as smoking in pregnancy, are the cause of their child's troubles.

Identifying a genetic condition, whether inherited or a sudden occurrence, exonerated parents over their child's problems and alleviated their feelings of guilt and responsibility.

In addition, a 'medical label' provides access to support and resources, including educational and other medical services.

For other families, however, identifying a genetic cause for the child's disorder can result in more unclear reactions, or even real distress.

Again, the reasons for this response are complex, including what the study calls the 'death of hope', because a genetic diagnosis can confirm that a child's troubles cannot be reversed or repaired.

And a genetic diagnosis may include a poor prognosis, or be seen to have grave ramifications for other, including future, family members.


'"/>

Contact: Becky Gammon
becky.gammon@esrc.ac.uk
44-179-341-3122
Economic & Social Research Council
23-Jun-2004


Page: 1 2

Related biology news :

1. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
2. Jay Levy honored with 2004 Abbott Laboratories Award in Clinical and Diagnostic Immunology
3. Melvin Weinstein wins 2004 BD Award for Research in Clinical Microbiology
4. DFG to establish seven new Clinical Research Units
5. Clinical trial patients dont care about study sponsors or physician conflicts of interest
6. NIH establishes Rare Diseases Clinical Research Network
7. Clinical study reports findings of combination therapy with DOXIL
8. Clinical study results published in NEJM show promising data on Antegren (natalizumab)
9. Clinical trial shows timing of chemotherapy improves survival in breast cancer
10. Clinical services must catch up
11. Clinical Advances towards the simplification if HIV therapy: First once-daily dosing results for the HIV protease inhibitor, Agenerase

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/22/2020)... ... April 21, 2020 , ... Captis Biotechnology, Inc. announced ... that provides patent development support for early stage startups. The investment will support ... ovarian cancer and precancerous pancreatic lesions with simple, accurate and practical technology. , ...
(Date:4/18/2020)... ... April 16, 2020 , ... SIRION Biotech GmbH , a world ... it will present a company update on its work expediting gene therapy research and ... on April 22 and 23. Dieter Lingelbach, the Company’s Chief Operating Officer, will also ...
(Date:4/16/2020)... , ... April 15, 2020 , ... ... working cell banks and hMSC bioprocess systems, announces that the Medical Technology Enterprise ... at MTEC’s 4th Annual Membership Meeting in March. The Regenerative Medicine (RegenMed) biomanufacturing ...
Breaking Biology News(10 mins):
(Date:4/22/2020)... WEST CHESTER, Ohio (PRWEB) , ... April 21, ... ... availability of Biophen™ FXIII chromogenic method for determination of FXIII. , Aniara Diagnostica, ... has strengthened its commitment to meeting today’s highest standards for product quality and ...
(Date:4/18/2020)... ... April 17, 2020 , ... NeuroFlow ... Innovation Research (SBIR) program to support the expansion of its digital health platform ... which conducts a rigorous merit-based review process, adds to NeuroFlow’s recent government ...
(Date:4/7/2020)... ... 06, 2020 , ... Red Nucleus, a leading provider of ... the release of at-home virtual learning resources for all client partners. , “With ... of our employees as we continue to implement measures to safeguard the well-being ...
(Date:4/1/2020)... (PRWEB) , ... March 30, 2020 , ... ... and telehealth developer Reliant Immune Diagnostics (RID), formed earlier this year to bring ... pandemic by creating in-home tests for COVID-19. Company officials are currently?awaiting an Emergency ...
Breaking Biology Technology:
Cached News: